Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 19;18(1):46.
doi: 10.1186/2047-783X-18-46.

Polyphenol extract of Phyllanthus emblica (PEEP) induces inhibition of cell proliferation and triggers apoptosis in cervical cancer cells

Affiliations

Polyphenol extract of Phyllanthus emblica (PEEP) induces inhibition of cell proliferation and triggers apoptosis in cervical cancer cells

Xinxian Zhu et al. Eur J Med Res. .

Abstract

Background: The aim of this study is to investigate the effects of polyphenol extract from Phyllanthus emblica (PEEP) on cervical cancer cells and to explore the underlying mechanism.

Methods: MTT assay was used to measure inhibition of proliferation of cervical cancer (HeLa) cells after treatment with PEEP at concentrations of 0, 50, 100, 150, and 200 mg/ml for 48 hours. HeLa cells were treated with PEEP (150 mg/ml) for 48 hours in the following analysis. Karyomorphism was assessed by immunofluorescence using DAPI staining, and cell apoptosis and cell cycle were assessed using flow cytometry. Three apoptotic marker proteins, namely, Fas, FasL, and cleaved caspase-8, were assessed by western blotting.

Results: PEEP inhibited the growth of HeLa cells, and the optimum concentration of PEEP was 150 mg/ml. In addition, the karyomorphism of HeLa cells after treatment with PEEP was abnormal. Furthermore, PEEP induced arrest of the HeLa cell cycle at G2/M phase, and triggered apoptosis. PEEP also induced significant Fas and FasL activation, and cleavage of caspase-8.

Conclusions: Our study indicates that PEEP is effective in inhibiting HeLa cell proliferation by inducing cell cycle arrest at G2/M phase and inducing apoptosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Polyphenol extract of Phyllanthus emblica (PEEP) inhibits HeLa cell proliferation. HeLa cells were treated with different concentrations of PEEP (50, 100, 150, 200 mg/ml) for 48 hours. Quantification of the number of viable cells was determined by MTT assay. The data are expressed as the means ± SD obtained from three independent experiments.
Figure 2
Figure 2
Polyphenol extract of Phyllanthus emblica (PEEP) induces cell cycle arrest of HeLa cells at G2/M phase. HeLa cells were treated with 0 mg/ml PEEP (A), 150 mg/ml PEEP (B) for 48 hours, and the cell cycle stage was determined by flow cytometry. The panels of M1, M2, and M3inside the image are the marks of stage borders of G0/G1, S, and G2/M, respectively.
Figure 3
Figure 3
Polyphenol extract of Phyllanthus emblica (PEEP) changes the karyomorphism of HeLa cells. HeLa cells were seeded onto coverslips, and treated with 0 mg/ml PEEP (A), 150 mg/ml PEEP (B) for 48 hours before harvesting. DAPI staining was used to highlight the nucleus. The panels inside the image represent the size of 10 μm.
Figure 4
Figure 4
Polyphenol extract of Phyllanthus emblica (PEEP) induces HeLa cell apoptosis. HeLa cells were treated with 0 mg/ml PEEP (A), 150 mg/ml PEEP (B) for 48 hours. The cells were harvested and resuspended in Guava Nexin. Cell cycle stage was determined by flow cytometry. The panels inside the image are marks of the quadrants, cells in the left lower quadrant are living cells, in the right upper quadrant are dead cells, and in the right lower quadrant are apoptotic cells.
Figure 5
Figure 5
Polyphenol extract of Phyllanthus emblica (PEEP) induces activation of Fas, FasL, and cleaved caspase-8. Western blotting analysis of Fas, FasL, and cleaved caspase-8 (Δ-caspase-8), in HeLa cells exposed to PEEP for 48 hours.

Similar articles

Cited by

References

    1. Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M. et al.Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99:1634–1643. doi: 10.1093/jnci/djm201. - DOI - PubMed
    1. Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X. A microRNA expression signature for cervical cancer prognosis. Cancer Res. 2010;70:1441–1448. doi: 10.1158/0008-5472.CAN-09-3289. - DOI - PMC - PubMed
    1. Kleinerman RA, Boice JD Jr, Storm HH, Sparen P, Andersen A, Pukkala E, Lynch CF, Hankey BF, Flannery JT. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer. 1995;76:442–452. doi: 10.1002/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L. - DOI - PubMed
    1. Yumin W, Jie C, Wenhui Z, Wangdong H, Fangyou Y. Study of the prevalence of human Papillomavirus infection in Chinese women with cervical cancer. Afr J Microbiol Res. 2012;6:1048–1053.
    1. Kumar V, Robbins SL. Robbins Basic Pathology. 8. Philadelphia, PA: Saunders/Elsevier; 2007.

MeSH terms